Clearance Summary
Helix Laboratory Platform received FDA 510(k) clearance under submission number DEN190035, sponsored by Helix Opco, LLC. The device was reviewed via the Direct premarket notification pathway and assigned to the Medical Genetics review panel. The statutory decision date of record is 2020-12-23.
- Submission: DEN190035
- Applicant / Sponsor: Helix Opco, LLC
- Clearance pathway: Direct
- Review panel: Medical Genetics
- Device class: Class II
- Regulation citation: 21 CFR 866.6000
- Decision date: 2020-12-23
Classification & Regulation
This clearance is catalogued under FDA product code QNC and 21 CFR 866.6000, within the Medical Genetics review panel as a Class II device.